Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rīgas Stradiņa Universitāte, Latvijas Valsts Koksnes Ķīmijas Institūts, AppfiledCriticalRīgas Stradiņa Universitāte
Priority to LVP-11-163ApriorityCriticalpatent/LV14499B/en
Publication of LV14499ApublicationCriticalpatent/LV14499A/en
Publication of LV14499BpublicationCriticalpatent/LV14499B/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
An invention belongs to medicine, chemistry and pharmacological industry and relates to use of compounds reducing malondialdehyde level in plasma.The invention provides a use of phenylpropanoid-lignin for this purpose.
LVP-11-163A2011-11-302011-11-30Agent for reducing high malondialdehyde level in plasma
LV14499B
(en)
Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5
Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same.